Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica B Langbaum

Showing results (21-30 of 67) with videos related to

Pageof 7
Sort By:
Communication Research|September 22, 2025
Spillover Effects of COVID-19 News Coverage on Willingness to Participate in Medical Research in a Diverse Sample of US Older AdultsAmy Bleakley, Erin K Maloney, Dannagal G Young, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 24, 2026
Outreach, Recruitment and Engagement Cores of NIA-designated Alzheimer's Disease Research Centers: Current strategies and future directionsCarol K Chan, Crystal M Glover, Monica Parker, et al.
International Psychogeriatrics|October 20, 2015
Diagnostic accuracy of CERAD total score in a Colombian cohort with mild cognitive impairment and Alzheimer's disease affected by E280A mutation on presenilin-1 geneDaniel Camilo Aguirre-Acevedo, Fabian Jaimes-Barragán, Eliana Henao, et al.
Alzheimer'S Research & Therapy|March 6, 2023
Rationale for the selection of dual primary endpoints in prevention studies of cognitively unimpaired individuals at genetic risk for developing symptoms of Alzheimer's diseaseAngelika Caputo, Amy Racine, Ines Paule, et al.
Nature Reviews. Neurology|June 12, 2013
Ushering in the study and treatment of preclinical Alzheimer diseaseJessica B Langbaum, Adam S Fleisher, Kewei Chen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersClaire M Erickson, Kristin Harkins, Elisabeth Wood, et al.
Frontiers in Neurology|February 8, 2021
Early Stages of Alzheimer's Disease: Evolving the Care Team for Optimal Patient ManagementJames E Galvin, Paul Aisen, Jessica B Langbaum, et al.
Health Education & Behavior : the Official Publication of the Society for Public Health Education|November 20, 2024
Theory-Based Message Design for Recruitment of Underrepresented Racial/Ethnic Groups Into Alzheimer's-Focused Research RegistriesAmy Bleakley, Erin K Maloney, Michael Hennessy, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 16, 2025
Donanemab in preclinical Alzheimer's disease: Screening and baseline data from TRAILBLAZER-ALZ 3Roy Yaari, Karen C Holdridge, Melissa Williamson, et al.
Alzheimer'S & Dementia (New York, N. Y.)|August 10, 2018
Adherence/Retention Alzheimer's Prevention Initiative Colombia PlanSilvia Rios-Romenets, Natalia Acosta-Baena, Liliana Lopez, et al.
Pageof 7

Showing results (21-30 of 67) with videos related to

Sort By:
Pageof 7
Communication Research|September 22, 2025
Spillover Effects of COVID-19 News Coverage on Willingness to Participate in Medical Research in a Diverse Sample of US Older AdultsAmy Bleakley, Erin K Maloney, Dannagal G Young, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 24, 2026
Outreach, Recruitment and Engagement Cores of NIA-designated Alzheimer's Disease Research Centers: Current strategies and future directionsCarol K Chan, Crystal M Glover, Monica Parker, et al.
International Psychogeriatrics|October 20, 2015
Diagnostic accuracy of CERAD total score in a Colombian cohort with mild cognitive impairment and Alzheimer's disease affected by E280A mutation on presenilin-1 geneDaniel Camilo Aguirre-Acevedo, Fabian Jaimes-Barragán, Eliana Henao, et al.
Alzheimer'S Research & Therapy|March 6, 2023
Rationale for the selection of dual primary endpoints in prevention studies of cognitively unimpaired individuals at genetic risk for developing symptoms of Alzheimer's diseaseAngelika Caputo, Amy Racine, Ines Paule, et al.
Nature Reviews. Neurology|June 12, 2013
Ushering in the study and treatment of preclinical Alzheimer diseaseJessica B Langbaum, Adam S Fleisher, Kewei Chen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersClaire M Erickson, Kristin Harkins, Elisabeth Wood, et al.
Frontiers in Neurology|February 8, 2021
Early Stages of Alzheimer's Disease: Evolving the Care Team for Optimal Patient ManagementJames E Galvin, Paul Aisen, Jessica B Langbaum, et al.
Health Education & Behavior : the Official Publication of the Society for Public Health Education|November 20, 2024
Theory-Based Message Design for Recruitment of Underrepresented Racial/Ethnic Groups Into Alzheimer's-Focused Research RegistriesAmy Bleakley, Erin K Maloney, Michael Hennessy, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 16, 2025
Donanemab in preclinical Alzheimer's disease: Screening and baseline data from TRAILBLAZER-ALZ 3Roy Yaari, Karen C Holdridge, Melissa Williamson, et al.
Alzheimer'S & Dementia (New York, N. Y.)|August 10, 2018
Adherence/Retention Alzheimer's Prevention Initiative Colombia PlanSilvia Rios-Romenets, Natalia Acosta-Baena, Liliana Lopez, et al.
Pageof 7